• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX 4.04% $24.74

TELIX PHARMACEUTICALS LIMITED - Corporate Spotlight

Telix Pharmaceuticals Limited is an Australia-based is a biopharmaceutical company... Telix Pharmaceuticals Limited is an Australia-based is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical devices. It develops a portfolio of clinical and commercial stage products that addresses significant unmet medical needs in oncology and rare diseases. It operates a pipeline of theranostic radiopharmaceutical product candidates with a focus in urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning. It operates under four business units: Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech), and Telix Manufacturing Solutions (TMS). Its lead imaging product is gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix). Its other pipelines include TLX591, TLX592, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

(20min delay)
Last
$24.74
Change
0.960(4.04%)
Mkt cap ! $6.278B
Open High Low Value Volume
$23.78 $24.91 $23.52 $39.12M 1.599M

Buyers (Bids)

No. Vol. Price($)
2 17165 $24.73
 

Sellers (Offers)

Price($) Vol. No.
$24.74 13333 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
Last
$24.80
  Change
0.960 ( 4.29 %)
Open High Low Volume
$23.86 $24.91 $23.52 383813
Last updated 15.59pm 29/11/2024 ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.